Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 39 PAGES: 44

More Info
									        Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME71FSA                                                                                             Publication Date: APR 2012

          3420 Central Expressway                            Phone              +1 408 7315000                  Revenue          267.5 (million USD)
          Santa Clara, CA                                    Fax                +1 408 7315380                  Net Profit       -28.16 (million USD)
          95051                                              Website            www.affymetrix.com              Employees        875
          United States                                      Exchange           AFFX [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       Affymetrix, Inc. (Affymetrix) is a medical equipment company engaged in the development, production, sales and service of
       consumables and equipment systems for genetic analysis in the life sciences and clinical healthcare markets. It offers products
       principally for two applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument systems,
       namely, GeneChip, GeneTitan and GeneAtlas that include instruments, consumables and software. The company’s platform is
       based on its GeneChip system and related microarray technology, which is used to acquire, analyze and manage complex
       genetic information.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Affymetrix, Inc., SWOT Analysis
         Frank Witney Ph.D.                  Chief Executive Officer                  Strengths                              Weaknesses
         Stephen P. A. Fodor, Ph.D.          Chairman
                                                                                      Proprietary Technology                 Revenue Concentration: the US
         John D. Diekman, Ph.D.              Director
                                                                                      Strong Research and                    Reliance on Suppliers
         Robert H. Trice, Ph.D.              Director
                                                                                      Development Activities
         Robert P. Wayman                    Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Strategic Collaborations               Government Regulations
         Affymetrix, Inc.
                                                                                      Potential Market                       Intense Competition
        Share Price (USD) as on 05-Apr-                                  4.25
        2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                       -0.40        GlobalData
        Market Cap (million USD)                                         310
        Enterprise Value (million USD)                                   204
        Shares Outstanding (million)                                       70
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Feb 23, 2012         Affymetrix Announces Immediate Shipment Of
                                                                                                           New Axiom Exome Genotyping Arrays
                                                                                      Feb 08, 2012         Affymetrix Reports Revenue Of $267.5m In
                                                                                                           2011
                                                                                      Nov 02, 2011         Affymetrix Reports Revenues Of $64m In Q3
                                                                                                           2011
                                                                                      Oct 06, 2011         Affymetrix Launches 18 New Microarrays For
                                                                                                           Gene Expression Analysis Of Model And
                                                                                                           Applied Research Organisms
       Source: Annual Report, Company Website, Primary and Secondary                 Source: Annual Report, Company Website, Primary and Secondary Research,
       Research, GlobalData                                                          GlobalData




Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis                                                                   Reference Code: GDME71FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Affymetrix, Inc. - Key Facts................................................................................................................................................................. 5
       Affymetrix, Inc. - Key Employees........................................................................................................................................................ 6
       Affymetrix, Inc. - Key Employee Biographies...................................................................................................................................... 7
       Affymetrix, Inc. - Major Products and Services ................................................................................................................................... 8
       Affymetrix, Inc. - History ................................................................................................................................................................... 10
       Affymetrix, Inc. - Locations And Subsidiaries ................................................................................................................................... 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Affymetrix, Inc. - Key Manufacturing Facilities .................................................................................................................................. 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       Affymetrix, Inc. - Business Description ............................................................................................................................................. 16
       Affymetrix, Inc. - Corporate Strategy ................................................................................................................................................ 18
       Affymetrix, Inc. - SWOT Analysis ..................................................................................................................................................... 19
          SWOT Analysis - Overview........................................................................................................................................................... 19
          Affymetrix, Inc. - Strengths............................................................................................................................................................ 19
             Strength - Proprietary Technology ............................................................................................................................................ 19
             Strength - Strong Research and Development Activities........................................................................................................... 19
          Affymetrix, Inc. - Weaknesses ...................................................................................................................................................... 19
             Weakness - Revenue Concentration: the US ............................................................................................................................ 19
             Weakness - Reliance on Suppliers ........................................................................................................................................... 20
          Affymetrix, Inc. - Opportunities...................................................................................................................................................... 20
             Opportunity - Strategic Collaborations....................................................................................................................................... 20
             Opportunity - Potential Market................................................................................................................................................... 20
             Opportunity - Market Growth in Emerging Economies .............................................................................................................. 20
          Affymetrix, Inc. - Threats ............................................................................................................................................................... 21
             Threat - Government Regulations ............................................................................................................................................. 21
             Threat - Intense Competition ..................................................................................................................................................... 21
             Threat - Industry Consolidation Challenges .............................................................................................................................. 21
       Affymetrix, Inc. - Key Competitors .................................................................................................................................................... 22
       Section 3 – Company Financial Ratios ............................................................................................................................................. 23
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 23
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 23
       Performance Chart ........................................................................................................................................................................... 25
       Financial Performance...................................................................................................................................................................... 25
       Financial Ratios - Interim Ratios....................................................................................................................................................... 26
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 27
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 28
          Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 .................................................................... 28
          Affymetrix, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 .................................................................... 29
          Affymetrix, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 ...................................................................................... 30
          Affymetrix, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012 ..................................................................................... 31


Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis                                                                                                     Reference Code: GDME71FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Affymetrix, Inc., Recent Deals Summary .......................................................................................................................................... 32
       Section 5 – Company’s Recent Developments ................................................................................................................................ 33
          Affymetrix, Inc., Recent Developments ......................................................................................................................................... 33
             Feb 23, 2012: Affymetrix Announces Immediate Shipment Of New Axiom Exome Genotyping Arrays .................................... 33
             Feb 08, 2012: Affymetrix Reports Revenue Of $267.5m In 2011 .............................................................................................. 34
             Nov 02, 2011: Affymetrix Reports Revenues Of $64m In Q3 2011 ........................................................................................... 34
             Oct 06, 2011: Affymetrix Launches 18 New Microarrays For Gene Expression Analysis Of Model And Applied Research
             Organisms ................................................................................................................................................................................. 35
             Aug 19, 2011: Affymetrix Announces Federal Court Affirms Dismissal Of Illumina Patent Infringement Lawsuits .................... 35
             Aug 08, 2011: Affymetrix Commercializes Next-Generation Transcriptome Array For Large-Scal
								
To top